Berenberg analyst Eoin Mullany upgrades Deutsche Bank (NYSE:DB) from Sell to Hold.
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
2seventy bio Inc's (NASDAQ: TSVT) anti-BCMA CAR-T got axed as part of a corporate update.